Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Melanoma 9Carcinoma, Renal Cell 4Sarcoma 3Prostatic Neoplasms 3Keratosis, Actinic 3Osteosarcoma 2Neoplasm Metastasis 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Wilms Tumor 1Uveal Melanoma 1Tongue Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Unknown Primary 1Neoplasms 1Kidney Neoplasms 1Intraocular Lymphoma 1

Interventions

Nivolumab 3fludarabine 2tipifarnib 1pembrolizumab 1humanized 3F8 anti-GD2 monoclonal antibody 1fludarabine phosphate 1bempegaldesleukin 1X-Rays 1Stem Cell Transplantation 1Specimen Handling 1Sirolimus 1Phantoms, Imaging 1Mesna 1Melphalan 1Ipilimumab 1Imatinib Mesylate 1Cyclophosphamide 1Cryotherapy 1Cryosurgery 1Busulfan 1Bone Density 1Alemtuzumab 1Albumin-Bound Paclitaxel 1Absorptiometry, Photon 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Cryosurgery × Dermatologic × Clear all
NCT05302921 2025-01-01

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Children's National Research Institute

Phase 2 Completed
5 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Melanoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡